AstraZeneca Will Take Over mGluR Program From NPS Pharmaceuticals For $30 Million
NPS says it will use the money to fund further development of late-stage candidates Preos and Gattex.
NPS says it will use the money to fund further development of late-stage candidates Preos and Gattex.